The Journal of Experimental Medicine
for flow cytometry > invitrogen
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published 15 October 2001. doi:10.1084/jem.194.8.1111
This Article
Right arrow Full Text
Right arrow Full Text (PDF, 379K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bouchon, A.
Right arrow Articles by Colonna, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bouchon, A.
Right arrow Articles by Colonna, M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?
© The Rockefeller University Press, 0022-1007/2001/10/1111/ $5.00
The Journal of Experimental Medicine, Volume 194, Number 8, October 15, 2001 1111-1122


Original Article

A Dap12-Mediated Pathway Regulates Expression of Cc Chemokine Receptor 7 and Maturation of Human Dendritic Cells

Axel Bouchona, Cristina Hernández-Munaina, Marina Cellaa, and Marco Colonnaa

a Basel Institute for Immunology, CH-4005 Basel, Switzerland
Department of Pathology and Immunology, Washington University School of Medicine, 660 South Euclid Ave., St. Louis, MO 63110.314-362-4096314-747-1221

mcolonna{at}pathology.wustl.edu

Gene targeting of the adaptor molecule DAP12 in mice caused abnormal distribution and impaired antigen presentation capacity of dendritic cells (DCs). However, the DAP12-associated receptors expressed on DCs and their functions have not been identified yet. Here we show that the triggering receptor expressed on myeloid cells-2 (TREM-2) is a cell surface receptor on human monocyte-derived DCs, which is associated with DAP12. TREM-2/DAP12 promotes upregulation of CC chemokine receptor 7, partial DC maturation, and DC survival through activation of protein tyrosine kinases and extracellular signal–regulated kinase. In contrast to Toll-like receptor-mediated signaling, TREM2/DAP12 stimulation is independent of nuclear factor-{kappa}B and p38 stress-activated protein kinase. This novel DC activation pathway may regulate DC homeostasis and amplify DC responses to pathogens, explaining the phenotype observed in DAP12-deficient mice.

Key Words: TREM • activation • human • survival • migration


M. Cella's present address is Department of Pathology and Immunology, Washington University School of Medicine, 660 South Euclid Ave., St. Louis, MO 63110.

Abbreviations used in this paper: CCR7, CC chemokine receptor 7; DC, dendritic cell; EMSA, electrophoretic mobility assay; ERK, extracellular signal–regulated kinase; HRP, horseradish peroxidase; ITAM, immunoreceptor tyrosine-based activation motif; MAPK, mitogen-activated protein kinase; MDL-1, myeloid DAP12-associating lectin-1; NF, nuclear factor; PTK, protein tyrosine kinase; SAPK, stress-activated protein kinase; SIRP-β, signal-regulatory protein β; TLR, Toll-like receptor; TREM, triggering receptor expressed on myeloid cells.

© 2001 The Rockefeller University Press


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS